Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2001The Journal of Clinical Endocrinology & MetabolismOpen Access

123IMetaiodobenzylguanidine and111InOctreotide Uptake in Benign and Malignant Pheochromocytomas1

View Full Paper
Ask AI
Bookmark
Share

Authors

EHErwin van der HarstMaasstad ZiekenhuisWHWouter W. de HerderUniversity of BernHBHajo A. BruiningErasmus MC

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Harst et al. (2001) studied this question.

synapsesocial.com/papers/6a6df29be36a167817e04023https://doi.org/10.1210/jcem.86.2.7238
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Diagnosis of pheochromocytoma using [123I]‐ compared with [131I]‐metaiodobenzylguanidine scintigraphy1999 · 114 citations
  2. 2Validation of Somatostatin Receptor Scintigraphy in the Localization of Neuroendocrine Tumors1993 · 34 citations
  3. 3MALIGNANT PHAEOCHROMOCYTOMA: CLINICAL, BIOCHEMICAL AND SCINTIGRAPHIC CHARACTERIZATION1984 · 132 citations